PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) announced the U.S. Court of Appeals for the Federal Circuit Court has ruled against the Company in its Angiomax® (bivalirudin) patent litigation with Hospira, Inc.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
